Expands requirements for health insurance carriers concerning prostate cancer screening and requires coverage be provided without cost sharing.

This bill requires health insurance carriers in New Jersey to cover prostate cancer screening without cost sharing (no deductibles, copays, or coinsurance). It expands the definition of "prostate cancer screening" to include more diagnostic methods beyond digital rectal exams and PSA tests, such as urinary analysis, serum biomarkers, and medical imaging. The coverage applies to men age 50+ who are asymptomatic, and men age 40+ with family history of prostate cancer or other risk factors. The bill extends these requirements to additional insurance types, including individual health insurance policies, that weren't previously required to cover prostate cancer screening under current law.